Evidence map›Paper›PMID 41329533›Full record

ArticlePhysiological research2025

Modulatory Effect of Nimbin on Isoproterenol Induced Mitochondrial and Lysosomal Enzymes Activities and Apoptosis Signaling in Rats.

Y Wang, J Chen, H Jiang, X Li

Abstract read
In one paragraph

Article in Physiological research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Y WangDepartment of Cardiovascular Medicine, First People's Hospital of Linping District, Hangzhou Zhejiang, China, Department of Nephrology, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangfan Hubei, China. lxq1468054582@sina.com.
J Chen
H Jiang
X Li

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nimbin, a bioactive triterpenoid compound isolated from the neem tree (Azadirachta indica), is known for its anti-inflammatory, antioxidant, antimicrobial, and hepatoprotective properties. The study aimed to explore the impact of nimbin on cardiac markers, mitochondrial and lysosomal enzyme activities, as well as apoptotic signaling in rats induced with isoproterenol. The subcutaneous injection of isoproterenol (ISO) at a dosage of 85 mg/kg body weight over the last two consecutive days led to notable increased in the activities/levels of the cardiac markers, lysosomal glycohydrolases and cathepsins. Conversely, reductions in the functioning of mitochondrial tricarboxylic acid cycle enzymes and respiratory chain enzymes in ISO-induced rats. In ISO-induced rats, there was an augmentation in the expressions of Bax, caspase-3, caspase-9, and cytochrome c, along with a diminished level of Bcl-2. Administration of nimbin resulted in decreased activities/levels cardiac markers, lysosomal glycohydrolases, cathepsins and increased functioning of mitochondrial tricarboxylic acid cycle enzymes and respiratory chain enzymes. Additionally, decreased expressions of Bax, executioner caspases and cytochrome c, along with heightened expression of Bcl-2, were noted in rats treated with nimbin. This indicates that nimbin possesses cardioprotective properties and mitigates mitochondrial and lysosomal dysfunction in rats induced with ISO. Key words Myocardial infarction " Tricarboxylic acid (TCA) cycle enzymes " Cathepsin-D " Cardiac markers " Triterpenoid.

Indexed as

ApoptosisIsoproterenolLimoninsLysosomesMitochondriaMitochondria, HeartAnimalsMaleRatsRats, WistarSignal TransductionIsoproterenolLimonins

Identifiers

PMID41329533
PMCPMC12746864

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.